Rosie Shaw is Head of Advocacy at Blood Cancer NZ. She has a background in health policy spanning New Zealand, the UK, and Australia, and now contributes towards national efforts to improve treatment access and outcomes for Kiwis living with blood cancer.

Dr Miriam Wronski is a neurologist at The Alfred Hospital in Melbourne, specialising in neuroimmunology and CAR-T cell therapy. She is also currently undertaking a PhD focused on clinical and paraclinical biomarkers to assist in the diagnosis and management of CAR-T cell therapy-associated neurotoxicity.

To be confirmed, either Mark Dowling or Nicole O'Leary will present

Rob Weinkove is Clinical Director at the Malaghan Institute, Consultant Haematologist at Health New Zealand, and Honorary Professor at University of Auckland. He leads a clinical and translational CAR T-cell programme at Malaghan, and contributes to clinical trials and guidelines for B-cell cancers and infection in the immunocompromised.

A BPT1 resident at St Vincent’s Hospital, he is developing a strong clinical foundation across general medicine while cultivating a keen interest in haematology. He aspires to pursue advanced training in the field after completing his basic training.

Dr Myles Wright is a palliative care physician and haematologist who works in Melbourne. He has a primary interest in improving the integration of palliative care for patients with advanced haematological cancers.